RMD FY 2023 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

FY 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.2B+18.0% YoY

Gross Profit

$2.4B55.8% margin

Operating Income

$1.1B26.8% margin

Net Income

$898M21.3% margin

EPS (Diluted)

$6.09

Cash Flow

Operating Cash Flow

$693M

Free Cash Flow

$559M

Stock-Based Comp.

$71M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$2.6B

Stockholders' Equity

$4.1B

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.2B	$3.6B	+18.0%
Gross Profit	$2.4B	$2.0B	+16.4%
Operating Income	$1.1B	$1.0B	+13.2%
Net Income	$898M	$779M	+15.2%